Polymorphisms in Apoptosis-Related Genes and Survival of Patients with Early-Stage Non-Small-Cell Lung Cancer
- 260 Downloads
This study was conducted to determine the association between single-nucleotide polymorphisms (SNPs) in apoptosis-related genes and survival outcomes of patients with early-stage non-small-cell lung cancer (NSCLC).
Three hundred ten consecutive patients with surgically resected NSCLC were enrolled. Twenty-five SNPs in 17 apoptosis-related genes were genotyped by a sequenome mass spectrometry-based genotyping assay. The genotype associations with overall survival (OS) and disease-free survival (DFS) were analyzed.
Three SNPs (TNFRSF10B rs1047266, TNFRSF1A rs4149570, and PPP1R13L rs1005165) were significantly associated with survival outcomes on multivariate analysis. When the three SNPs were combined, OS and DFS were decreased as the number of bad genotypes increased (P trend for OS and DFS = 7 × 10−5 and 1 × 10−4, respectively). Patients with one bad genotype, and patients with two or three bad genotypes had significantly worse OS and DFS compared with those with no bad genotypes [adjusted hazard ratio (aHR) for OS = 2.27, 95% confidence interval (CI) = 1.22–4.21, P = 0.01, aHR for DFS = 1.74, 95% CI = 1.08–2.81, P = 0.02; aHR for OS = 4.11, 95% CI = 2.03–8.29, P = 8 × 10−5; and aHR for DFS = 2.89, 95% CI = 1.64–5.11, P = 3 × 10−4, respectively].
Three SNPs in apoptosis-related genes were identified as possible prognostic markers of survival in patients with early-stage NSCLC. The SNPs, and particularly their combined genotypes, can be used to identify patients at high risk for poor disease outcome.
KeywordsOverall Survival Survival Outcome Polymerase Chain Reaction Restriction Fragment Length Polymorphism Resected NSCLC Poor Survival Outcome
This study was supported by the National R&D Program for Cancer Control Ministry of Health & Welfare (0720550-2) and the Regional Technology Innovation Program of the Ministry of Commerce, Industry and Energy (RTI04-01-01) of Republic of Korea.
The authors indicated no commercial interest.
- 29.Kim S, Moon SM, Kim YS, et al. TNFR1 promoter -329G/T polymorphism results in allele specific repression in TNFR1 expression. Biochem Biophys Res Commun. 2008;368–401.Google Scholar
- 30.Yang JP, Hori M, Sande T, Okamoto T. Identification of a novel inhibitor of nuclear factor-кB, RelA-associated inhibitor. J Biol Chem. 1999;18:6938–47.Google Scholar
- 33.Vogel U, Laros I, Jacobsen NR et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mut Res. 2004;546:65–74.Google Scholar
- 35.Takenaka T, Yano T, Kiyohara C, et al. Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients. Lung Cancer. 2009 (in press).Google Scholar